-
Mashup Score: 12Higher-Dose Atypical Antipsychotics Risky in Young Adults - 4 month(s) ago
Higher doses of a second-generation antipsychotic are associated with an increased risk of dying in young adults aged 18-24 years, results of a large retrospective cohort study showed.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Brexpiprazole versus placebo or other antidepressive agents for treating depression - Ralovska, S - 2023 | Cochrane Library - 9 month(s) ago
Collapse all Expand all Background Brexpiprazole is the newest antipsychotic drug approved as an adjunctive for treatment‐resistant depression. This systematic review provides comprehensive, high‐quality evidence for the effects of brexpiprazole in major depressive disorder (MDD) based on existing and emerging randomised controlled trials (RCTs). Objectives To evaluate the benefits and…
Source: www.cochranelibrary.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 4Underused Med May Curb Schizophrenia's 'Most Dreaded Outcome' - 1 year(s) ago
An analysis of postmortem records showed fewer suicides among individuals with schizophrenia who were taking clozapine, an underutilized antipsychotic, compared to those taking other antipsychotics.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 3
ABSTRACT Objective: To examine the impact of antipsychotic dose adjustments (mainly reduction) on the efficacy and tolerability of antipsychotic medications (APMs) to facilitate hospital discharge in long-term hospitalized forensic patients with treatment-refractory psychosis. Methods: This was a retrospective review of the medical charts of 22 patients with psychosis who were discharged from…
Source: Psychiatrist.comCategories: Latest Headlines, PsychiatryTweet
-
Mashup Score: 2
ABSTRACT Objective: To examine the impact of antipsychotic dose adjustments (mainly reduction) on the efficacy and tolerability of antipsychotic medications (APMs) to facilitate hospital discharge in long-term hospitalized forensic patients with treatment-refractory psychosis. Methods: This was a retrospective review of the medical charts of 22 patients with psychosis who were discharged from…
Source: Psychiatrist.comCategories: Latest Headlines, PsychiatryTweet
-
Mashup Score: 1Diagnoses and Treatment in Juvenile Detention Before and After Evaluation by Facility-Based Mental Health Service - 2 year(s) ago
As of 2018, more than 37,000 American youth were residing in juvenile detention or residential placement facilities.1 Prevalence studies have demonstrated high rates of psychiatric illness in this population, with estimates ranging from 50% to 75%.2,3 Comorbidity is common: Abram et al. found that 75% of juvenile detainees meeting criteria for one disorder met criteria for two or more disorders.4…
Categories: Latest Headlines, PsychiatryTweet-
#Juveniledetention #mentalhealth services were associated with significantly more trauma-related, depressive, & #substanceuse diagnoses compared to community providers, in addition to significantly fewer #antipsychotic and #moodstabilizer prescriptions. https://t.co/YmrHN1noSh https://t.co/RjIYL8eloQ
-
-
Mashup Score: 0
Researchers completed a literature review to determine if recommendations for maintenance treatment or for switching antipsychotic medication prevent relapse in people with chronic psychosis.
Source: Neurology AdvisorCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 2Add-On Pramipexole for the Treatment of Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial - 2 year(s) ago
ABSTRACT Objective: Several small clinical trials have reported that the dopamine agonist pramipexole was beneficial in treating patients with schizophrenia. A confirmatory trial was conducted to test this hypothesis. Methods: This 16-week, multicenter, double-blind, randomized, placebo-controlled study included 200 subjects meeting DSM-IV-TR criteria for schizophrenia or schizoaffective…
Source: Psychiatrist.comCategories: Latest Headlines, PsychiatryTweet
-
Mashup Score: 1
To evaluate 1) whether early nonresponse to antipsychotics predicts nonresponse and nonremission, 2) patient and illness characteristics as outcome predictors, and 3) response prediction of 30-item Positive and Negative Syndrome Scale (PANSS-30) compared with 6-item PANSS (PANSS-6) and Clinical Global Impressions–Improvement Scale (CGI-I) in youths with first-episode psychosis.
Categories: Latest Headlines, PsychiatryTweet-
Poor response to #antipsychotic medication within first 2-4 weeks in youth with first-episode #psychosis predicts poor response in the longer run: a switch in #antipsychoticdrug should be considered early, instead of awaiting further improvement. #JAACAP https://t.co/URsmApth6v https://t.co/YpMYX1arHf
-
-
Mashup Score: 3Early Metformin Minimizes Antipsychotic-Induced Weight Gain - 2 year(s) ago
A new guideline provides a protocol for the use of metformin, an inexpensive drug that has the most evidence for efficacy against antipsychotic-induced weight gain.
Source: MedscapeCategories: Latest Headlines, PsychiatryTweet
High doses of a second-generation #antipsychotic are associated with a significantly increased risk for death in young adults. https://t.co/dkOouDMD8e https://t.co/D8M4TK4ia4